InvestorsHub Logo
Followers 144
Posts 8676
Boards Moderated 0
Alias Born 10/07/2013

Re: Number sleven post# 384295

Monday, 07/25/2022 7:24:49 PM

Monday, July 25, 2022 7:24:49 PM

Post# of 424555
N-

If BASF wasn't under contract to supply Amarin, why wouldn't they be supplying the generic companies?

Because BASF does not supply anybody in the US (with pure EPA)

(i) They have
- Maxomega EPA 97 EE for Japanese market
- Omega-3-Acid Ethyl Esters (K85EE) for Japanese Market
- Omega-3-Acid Ethyl Esters (K85EE) for US Market

(ii) from TerraPharma (@Twitter)
April 13, 2020:

Points out that epadel api can't be changed over to vascepa api as it's different & then would need to be further approved by FDA (DMF)..(I believe that's a shot across bow to BASF). Says suppliers have told us they've been approached by generics & turned them down

April 14, 2020:

Nope. It needs to be addressed still. BASF was once under contract as an API supplier to AMRN and they until recently advertised API for epadel and Vascepa on their website until the Vascepa reference disappeared after Amarin was notified. Coincidence?

Best,
G

Disclosure: I wrote this post myself, and it expresses my own opinions (IMHO). I am not receiving compensation for it.

Notice: This post is not investment advice, and not a recommendation to neither buy nor hold nor sell.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News